Current role
Rob Myers, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Rob Myers, M.D.
Mirum Pharmaceuticals, Inc. reported in an 8-K filed September 8, 2026 that Rob Myers, M.D. was appointed Chief Medical Officer, effective September 21, 2026.
“On September 8, 2026, Mirum Pharmaceuticals, Inc. (the “Company”) announced that, on September 2, 2026, the Company’s Board of Directors appointed Rob Myers, M.D., to succeed Joanne Quan, M.D., as the Company’s Chief Medical Officer, effective upon Dr. Myers’ beginning employment with the Company, which employment is expected to begin on September 21, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-09-21–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Mirum Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Christopher Peetz CEO
- Michael Grey CEO
- Eric Bjerkholt CFO
- Peter Radovich COO
- Lon Cardon, Ph.D., FMedSci Board Member
- Saira Ramasastry Board Member
- Timothy Walbert Board Member
- To approve Board Member
- William Fairey Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.